EPIM
TEVA icon

Echo Point Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Echo Point Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$19.2M Sell
508,688
-18,516
-4% -$722K 73.64% 1
2013
Q2 		$20.7M Buy
+527,204
New +$20.5M 73.79% 1

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Echo Point Investment Management's TEVA Position: Q3 2013 in Review

Echo Point Investment Management reduced its Teva Pharmaceuticals (TEVA) stake by 3.5% in Q3 2013, selling an estimated $722K and leaving 508,688 shares worth $19.2M. The position accounts for 73.64% of the portfolio, ranked #1.

Echo Point Investment Management first reported a position in TEVA in Q2 2013 and has held it in 2 quarters since. The position peaked at $20.7M in Q2 2013. 705 funds tracked by Wall St. Rank hold TEVA as of Q3 2013.

  • Echo Point Investment Management held 508,688 shares of Teva Pharmaceuticals worth $19.2M as of Q3 2013.
  • Echo Point Investment Management sold 18,516 Teva Pharmaceuticals shares in Q3 2013, an estimated $722K.
  • Teva Pharmaceuticals made up 73.64% of Echo Point Investment Management's portfolio in Q3 2013, its #1 holding.
  • Echo Point Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 2 quarters since.
  • Echo Point Investment Management's Teva Pharmaceuticals position peaked at $20.7M in Q2 2013.
  • 705 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2013.

Based on Echo Point Investment Management's 13F filing for Q3 2013, filed 5 Nov 2013.